Milestone

In 2010,

Bioperfectus was founded in Shanghai.

In 2013,

Avian Influenza H7N9 outbroke. Bioperfectus developed the first H7N9 real-time PCR kit in China.

In 2014,

During Ebola Virus outbreak in Africa, Bioperfectus Ebola real-time PCR kits were donated to Africa.

In 2015,

Bioperfectus hand-food-mouth disease products were supported by National Torch Program.

In 2016,

Bioperfectus was invited to be the official supplier of infectious disease testing during the G20 Summit held in Hangzhou, China.  

In 2019,

Bioperfectus was listed in Shanghai Stock Exchange.

In 2018,

Bioperfectus became the supplier of emergency reagents for infectious diseases at the Qingdao Shanghai Cooperation Summit.

In 2017,

Bioperfectus launched the first H7N4 avian influenza Real-Time PCR in China.  In the same year, Bioperfectus was invited to be the official supplier of infectious disease testing during the "Belt and Road Forum for International Cooperation" in Beijing, China.

From 2020 until nowadays

Bioperfectus has launched a series of diagnostic pipelines including respiratory infectious diseases, sexually transmitted diseases, vector-borne diseases, zoonosis infectious diseases, gastrointestinal infectious diseases, life sciencenucleic acid extraction solutions and real-time PCR system to assist the globe in fighting against the infectious diseases.

 

 

In August 2020

Bioperfectus Nucleic Acid Extraction Kit (Magnetic Bead Method), Bioperfectus Nucleic Acid Isolation Kit (Silica Based Spin Column Method), Bioperfectus Nucleic Acid Extraction System (SSNP-2000B, SSNP-3000A, SSNP-9600A) obtained FDA Listed.

 

On July 9, 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted of World Health Organization Emergency Use Listing (WHO-EUL).

 

On June 18, 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted an Emergency Use Authorization by the US Food and Drug Administration (EUA-FDA).

 

On June 1, 2020

International Sales and Marketing Division was established.

 

On May 5, 2020

COVID-19 Coronavirus Real Time PCR Kit developed by Bioperfectus was certified by the Australian Drug Administration Therapeutic Goods Administration (TGA);

 

On March 6, 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was awarded the CE certification;

a leading molecular diagnostic solution provider